Moreover, HERG1 was found to be significantly upregulated in other types of cancer, such as hepatocellular carcinoma, bladder cancer, gastric cancer, and ovarian cancer (Fig. 1e). Here, KCNH2 is linked to hepatocellular carcinoma.